| HOME >> BIOLOGY >> TECHNOLOGY |
Change in operating assets and
liabilities:
Accounts receivable (960,482) (517,358)
Notes receivable (433,843)
Other receivables 1,285 (494,298)
Other receivables - shareholders 1,398 (604,391)
Inventories (1,585,462) (498,242)
Prepayments and deferred
expenses (96,457) 44,701
Accounts payable (310,692) 145,858
Other payables and accrued
liabilities 101,089 651,234
Customer deposits 927,456
Taxes payable 871,964 382,165
Contingent liability (105,707)
Net cash provided by operating 2,018,879 1,235,082
activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Additions to plant and equipment (1,249,620) (1,151,674)
Additions to construction in
progress (151,066)
Additions to intangible assets (3,285)
Advances on building, equipment and
intangible assets purchases (106,777) (560,523)
Net cash used in investing
activities (1,359,682) (1,863,263)
CASH FLOWS FINANCING ACTIVITIES:
Proceeds from short term loan - bank 1,290,100
Payments on short term loan - bank (698,850)
Payments on long term debt (129,010)
Dividends paid to minority
'/>"/>
| SOURCE China Biologic Products, Inc. Copyright©2008 PR Newswire. All rights reserved |